SLC4A11 Mitochondrial Uncoupling and ROS Production in Corneal Endothelium
SLC4A11 角膜内皮线粒体解偶联和 ROS 产生
基本信息
- 批准号:10393579
- 负责人:
- 金额:$ 41.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
“SLC4A11 Mitochondrial Uncoupling and ROS Production in Corneal Endothelium”
ABSTRACT
Defects in the gene SLC4A11 cause Congenital Hereditary Endothelial Dystrophy and some forms of
Fuchs Dystrophy. The goal of this study is to understand the role of this membrane transporter in normal corneal
endothelial metabolism and how SLC4A11 deficiency leads to Corneal Dystrophy. The corneal endothelial
“pump” maintains corneal hydration and transparency. When the “pump” fails due to trauma, inflammation,
ageing, or dystrophy, corneal edema ensues, transparency is lost, and vision is significantly degraded. The usual
therapy is transplantation, which is not without significant compromises and complications. A hallmark of Corneal
Endothelial Dystrophies is mitochondrial dysfunction. Our laboratory has shown that SLC4A11 is an NH3
dependent electrogenic H+ transporter. We have found that glutamine is actively metabolized by the endothelium
producing NH3 and enhancing ATP formation. Slc4a11 knock out shows significant corneal edema, lactate
accumulation, altered mitochondrial physiology, and ROS. These data have led to the overarching hypothesis
that corneal endothelium actively metabolize glutamine and that the absence of SLC4A11 alters glutamine
metabolism, leading to mitochondrial dysfunction, ROS, and eventual apoptosis. Preliminary data indicate that
SLC4A11 is both a plasma membrane and a mitochondrial membrane protein, leading to the novel hypothesis
that SLC4A11 is a mitochondrial uncoupler. Using multiple in vitro & in vivo complementary approaches these
hypotheses will be tested in three aims. Aim 1 will determine how glutamine metabolism is facilitated in Corneal
Endothelial mitochondria. The hypothesis is that Slc4a11 is an NH3 sensitive mitochondrial uncoupler that works
in conjunction with Uncoupling Protein-2 and the potential mitochondrial buffer taurine to facilitate Glutamine
catabolism. Aim 2 will examine the source of ROS and ROS as a stimulus to Apoptosis in Slc4a11 KO. Our
hypothesis is that apoptosis is accelerated by ROS, which is generated by the interaction of NH3 with an
energized electron transport chain and reduced by SLC4A11 uncoupling. Aim 3 will identify the cause of corneal
edema in Slc4a11 KO Mice. We will test the hypothesis that loss of Slc4a11 secondarily induces downregulation
of key proteins that facilitate lactate transport. Completion of this study will establish the role of SLC4A11 and
glutamine in endothelial metabolism; provide new insight for mechanisms that facilitate glutamine metabolism
yet alleviate NH3 induced ROS production that will be transferable to a wide array of glutamine metabolizing
tissues; and provide insight for development of therapies for endothelial dystrophies.
“角膜内皮中的线粒体解偶联和ROS产生” SLC4A11”
抽象的
基因SLC4A11的缺陷导致先天性遗传性内皮营养不良和某些形式
富克斯营养不良。这项研究的目的是了解该膜转运蛋白在正常角膜中的作用
内皮代谢以及SLC4A11缺乏如何导致角膜营养不良。角膜内皮
“泵”保持角膜水合和透明度。当“泵”因创伤,炎症而失败时,
衰老或营养不良,随之而来的是角膜水肿,透明度会丧失,视力显着降解。通常
治疗是移植,这并非没有重大折衷和并发症。角膜的标志
内皮营养不良是线粒体功能障碍。我们的实验室表明SLC4A11是NH3
依赖性的电源H+转运蛋白。我们发现谷氨酰胺被内皮积极代谢
产生NH3并增强ATP形成。 slc4a11敲出显示明显的角膜水肿,乳酸
积累,线粒体生理改变和ROS。这些数据导致了总体假设
角膜内皮积极代谢谷氨酰胺,而SLC4A11的缺失会改变谷氨酰胺
代谢,导致线粒体功能障碍,ROS和最终凋亡。初步数据表明
SLC4A11既是质膜,也是线粒体膜蛋白,导致了新的假设
该SLC4A11是线粒体解耦合器。使用多个体外和体内完成方法
假设将以三个目标进行检验。 AIM 1将确定如何在角膜中制备谷氨酰胺代谢
内皮线粒体。假设是SLC4A11是一种有效的NH3敏感线粒体解耦合器
与解偶联蛋白2和电势线粒体缓冲牛磺酸结合使用以促进谷氨酰胺
分解代谢。 AIM 2将检查ROS和ROS的来源,作为SLC4A11 KO中凋亡的刺激。我们的
假设是凋亡是由ROS加速的,ROS是由NH3与A的相互作用产生的
电动电子传输链,并通过SLC4A11解耦合降低。 AIM 3将确定角膜的原因
SLC4A11 KO小鼠的水肿。我们将测试以下假设:SLC4A11次要损失会引起下调
促进乳酸转运的关键蛋白质。这项研究的完成将确定SLC4A11和
内皮代谢中的谷氨酰胺;为促进谷氨酰胺代谢的机制提供新的见解
然而,减轻NH3诱导的ROS产量将转移到广泛的谷氨酰胺代谢中
组织;并为内皮营养不良的疗法开发提供见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Joseph Aurelio Bonanno其他文献
Bicarbonate transport mechanisms in rabbit ciliary body epithelium.
兔睫状体上皮中碳酸氢盐的转运机制。
- DOI:
- 发表时间:19911991
- 期刊:
- 影响因子:3.4
- 作者:J. Wolosin;Joseph Aurelio Bonanno;D. K. Hanzel;D. K. Hanzel;Terry E. Machen;Terry E. MachenJ. Wolosin;Joseph Aurelio Bonanno;D. K. Hanzel;D. K. Hanzel;Terry E. Machen;Terry E. Machen
- 通讯作者:Terry E. MachenTerry E. Machen
共 1 条
- 1
Joseph Aurelio Bon...的其他基金
SLC4A11 Mitochondrial Uncoupling and ROS Production in Corneal Endothelium
SLC4A11 角膜内皮线粒体解偶联和 ROS 产生
- 批准号:1061566110615661
- 财政年份:2020
- 资助金额:$ 41.2万$ 41.2万
- 项目类别:
VISION RESEARCH AT INDIANA UNIVERSITY
印第安纳大学视觉研究
- 批准号:69449896944989
- 财政年份:2005
- 资助金额:$ 41.2万$ 41.2万
- 项目类别:
VISION RESEARCH AT INDIANA UNIVERSITY
印第安纳大学视觉研究
- 批准号:71268127126812
- 财政年份:2005
- 资助金额:$ 41.2万$ 41.2万
- 项目类别:
VISION RESEARCH AT INDIANA UNIVERSITY
印第安纳大学视觉研究
- 批准号:74738537473853
- 财政年份:2005
- 资助金额:$ 41.2万$ 41.2万
- 项目类别:
VISION RESEARCH AT INDIANA UNIVERSITY
印第安纳大学视觉研究
- 批准号:72830077283007
- 财政年份:2005
- 资助金额:$ 41.2万$ 41.2万
- 项目类别:
相似国自然基金
温度作用下CA砂浆非线性老化蠕变性能的多尺度研究
- 批准号:12302265
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于波动法的叠层橡胶隔震支座老化损伤原位检测及精确评估方法研究
- 批准号:52308322
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
微纳核壳结构填充体系构建及其对聚乳酸阻燃、抗老化、降解和循环的作用机制
- 批准号:52373051
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
东北黑土中农膜源微塑料冻融老化特征及其毒性效应
- 批准号:42377282
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
高层建筑外墙保温材料环境暴露自然老化后飞火点燃机理及模型研究
- 批准号:52376132
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
- 批准号:1067834110678341
- 财政年份:2023
- 资助金额:$ 41.2万$ 41.2万
- 项目类别:
Mitochondrial electron transport dysfunction: Dissecting pathomechanisms
线粒体电子传递功能障碍:剖析病理机制
- 批准号:1067998810679988
- 财政年份:2023
- 资助金额:$ 41.2万$ 41.2万
- 项目类别:
Preclinical Development of a Novel Therapeutic Agent for Idiopathic Pulmonary Fibrosis
特发性肺纤维化新型治疗剂的临床前开发
- 批准号:1069653810696538
- 财政年份:2023
- 资助金额:$ 41.2万$ 41.2万
- 项目类别:
Stabilizing the tripartite synaptic complex following TBI
TBI 后稳定三方突触复合体
- 批准号:1084487710844877
- 财政年份:2023
- 资助金额:$ 41.2万$ 41.2万
- 项目类别:
A bioluminescent-based imaging probe for noninvasive longitudinal monitoring of CoQ10 uptake in vivo
基于生物发光的成像探针,用于体内 CoQ10 摄取的无创纵向监测
- 批准号:1082971710829717
- 财政年份:2023
- 资助金额:$ 41.2万$ 41.2万
- 项目类别: